#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pouchitis Subdural haematoma Postprandial hypoglycaemia Cardiac arrest Chronic graft versus host disease T-cell type acute leukaemia Endometrial adenocarcinoma Pleural mesothelioma Langerhans cell sarcoma Polycystic liver disease Chorioretinitis Medulloblastoma recurrent Follicular lymphoma stage I Piriformis syndrome Ovarian cancer stage IV More trials…

    Learn about Rare Diseases

    Phenylketonuria – Treatment Andersen-Tawil syndrome – Trials in Disease Lymphatic malformation X-linked lymphoproliferative syndrome – Trials in Disease Cytokine release syndrome – Life with Disease Thrombotic thrombocytopenic purpura – Basic Information VEXAS syndrome – Basic Information Soft tissue sarcoma Progressive supranuclear palsy – Life with Disease Basal cell naevus syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Marstacimab Amiodarone Hydrochloride Radotinib Dihydrochloride Rituximab GSK5784283 Chlorphenamine Lansoprazole Sebetralstat Cipepofol Dexpanthenol Rtx001 Inclisiran Roxithromycin Rbd4059 Alanyl Glutamine Vonafexor Elenestinib Phosphate Eltrombopag LUNSEKIMIG Dalbavancin More therapies…

    Learn about Your Condition

    Oxygen therapy Drug dependence Ovarian cancer recurrent Death neonatal Femur fracture Neonatal respiratory failure Nodular melanoma Infection Acute on chronic liver failure Bladder cancer stage II Post procedural complication HER2 positive gastric cancer Anal fistula Meniere's disease Peritonitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Ferric Derisomaltose on Mobility in Elderly Patients After Hip Fracture Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hip fracture
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Denmark

  • Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Vortioxetine Hydrobromide
    • Chlorpromazine Hydrochloride
    • Haloperidol Decanoate
    Spain

  • Study on Simvastatin for Reducing Liver Fibrosis in Patients with Advanced Alcohol-Related Liver Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    • Liver disorder
    • Alcoholic liver disease
    Investigated Drugs:
    • Simvastatin
    Spain

  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Chronic lymphocytic leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • IDP-121
    Spain

  • Study on the Effectiveness of PRGF Eye Drops for Treating Dry Eye in Glaucoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study on Lutetium (177Lu) Zadavotide Guraxetan for Prostate Cancer Patients with Biochemical Recurrence After Initial Curative Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 3,3-Diphosphono-1,2-Propanedicarboxylic Acid, Tetrasodium Salt (Dpd)
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Gozetotide
    Austria
Previous Page
1 … 291 292 293 294 295 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!